Crick — Clinical Intelligence Platform

Not applicableUnknownNCT05571371

What this trial is testing

Inflammatory Biomarkers in Psychogenic Non-epileptic Seizure

Who this might be right for

Localization-Related (Focal) (Partial) Idiopathic Epilepsy and Epileptic Syndromes With Seizures of Localized OnsetTRAIL: Tumor Necrosis Factor Related Apoptosis Inducing Ligand MCP-2MCP-2: Monocyte Chemo-attractant Protein-2

Esraa Mostafa Ahmed Abdel Aal 90

Results for “Epilepsy With Partial-onset Seizures”

Open-label, Randomized, Active-controlled Study of LEV Used as Monotherapy in Patients With Partial-Onset Seizures

Investigate How Effective, Safe and Tolerable the Drug NBI-921352 is When Used With Anti-seizure Medications in Adults With Focal Onset Seizures

A Placebo-controlled Study of Efficacy & Safety of 2 Trough-ranges of Everolimus as Adjunctive Therapy in Patients With Tuberous Sclerosis Complex (TSC) & Refractory Partial-onset Seizures

Determine if BHV-7000 is Effective and Safe in Adults With Refractory Focal Onset Epilepsy

Open-label Study to Evaluate the Safety and Tolerability of iv Lacosamide in Japanese Adults With Partial-onset Seizures

Open-label Extension Study of the Phase 3 VRX-RET-E22-301 Double-Blind Trial

A Randomized, Controlled Trial of Ganaxolone in Adult Uncontrolled Partial-Onset Seizures

An Open-Label Extension Study to Evaluate the Safety and Tolerability of RWJ 333369 as Adjunctive Therapy in Patients 16 Years and Older With Partial Onset Seizures.

Study of the Pharmacokinetics, Safety, and Tolerability of ZONISADE in Children 1 Month to 17 Years of Age With Partial-onset Seizures

Open-label Long-term Study of Adjunctive Brivaracetam in Pediatric Subjects With Epilepsy

Levetiracetam: The Anti-Convulsant of Choice for Elderly Patients With Dementia

ZAGAL Study: Evaluating Effectiveness and Tolerability of Zonisamide as Adjunctive Therapy in Patients With Partial Onset Seizures Treated With Two Antiepileptic Drugs

Open-label Extension Study to Evaluate the Safety of USL255 in Patients With Refractory Partial-onset Seizures

Inflammatory Biomarkers in Psychogenic Non-epileptic Seizure

PuLsE 2-Observational Long-Term Effectiveness Follow-Up Study of PuLsE 1

Prospective Pilot Study on Metabolism and Weight Changes in Topiramate-Treated Epilepsy Patients

Eslicarbazepine Acetate (BIA 2-093) as Monotherapy in Patients With Newly Diagnosed Partial-onset Seizures

Trial Comparing the Efficacy and Safety of Lacosamide (LCM) to Carbamazepine Controlled-Release (CBZ-CR); Initial Monotherapy in Epilepsy; Subjects Aged 16 and Older

Lacosamid-i.v.-Register

The Effectiveness and Safety of Topiramate Monotherapy in Patients With Recently Diagnosed Partial-Onset Seizure